XNYSEHAB
Market cap382mUSD
Jan 10, Last price
7.60USD
1D
-2.56%
1Q
5.56%
IPO
-66.58%
Name
Enhabit Inc
Chart & Performance
Profile
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
Income | |||||
Revenues | 1,046,300 -3.40% | 1,083,100 -2.12% | |||
Cost of revenue | 977,200 | 942,500 | |||
Unusual Expense (Income) | |||||
NOPBT | 69,100 | 140,600 | |||
NOPBT Margin | 6.60% | 12.98% | |||
Operating Taxes | (11,400) | 28,900 | |||
Tax Rate | 20.55% | ||||
NOPAT | 80,500 | 111,700 | |||
Net income | (80,500) -228.80% | 62,500 -43.74% | |||
Dividends | (654,900) | ||||
Dividend yield | 99.33% | ||||
Proceeds from repurchase of equity | (595,100) | ||||
BB yield | 90.26% | ||||
Debt | |||||
Debt current | 46,100 | 37,100 | |||
Long-term debt | 630,200 | 630,200 | |||
Deferred revenue | |||||
Other long-term liabilities | 21,500 | 1,900 | |||
Net debt | 648,900 | 644,400 | |||
Cash flow | |||||
Cash from operating activities | 48,400 | 80,100 | |||
CAPEX | (3,500) | (7,100) | |||
Cash from investing activities | (5,300) | (42,300) | |||
Cash from financing activities | (40,500) | (18,600) | |||
FCF | 72,900 | 73,900 | |||
Balance | |||||
Cash | 27,400 | 22,900 | |||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | 286,500 | 471,400 | |||
Invested Capital | 1,345,400 | 1,505,400 | |||
ROIC | 5.65% | 7.35% | |||
ROCE | 5.14% | 9.08% | |||
EV | |||||
Common stock shares outstanding | 49,900 | 50,100 | |||
Price | 10.35 -21.35% | 13.16 | |||
Market cap | 516,465 -21.67% | 659,312 | |||
EV | 1,197,365 | 1,337,412 | |||
EBITDA | 100,000 | 174,200 | |||
EV/EBITDA | 11.97 | 7.68 | |||
Interest | 43,000 | 15,000 | |||
Interest/NOPBT | 62.23% | 10.67% |